Answers are grounded in this paper and cite their sources.
Latent tuberculosis infection (LTBI) is a major health challenge globally, which constitutes a large reservoir for future active disease and transmission. Currently, diagnostic tests, including the tuberculin skin test and interferon-γ release assays, have limited ability to distinguish LTBI from active disease and to predict disease progression. Therefore, this study aimed to evaluate host-derived serum RNA biomarkers using a real-time qPCR assay for the rapid identification of LTBI. The study population consisted of 143 individuals, including the primary study population ( n = 93) categorized into 3 groups: active tuberculosis ( n = 20), latent tuberculosis infection ( n = 54), and contact tracing ( n = 19), and an additional independent household-contact cohort of 50 individuals with six months of follow-up was included to provide an independent assessment of the reproducibility of candidate transcript detection patterns. Serum samples were separated, and total RNA was extracted, followed by cDNA synthesis. The relative abundance of five circulating transcripts ( CXCL10 , L6 , CVIL , LIMD2 , and ARSA1 ) was determined using SYBR Green-based real-time qPCR, with B2M as the housekeeping reference transcript for normalization. Relative abundance of circulating transcripts was calculated using the 2^−ΔΔCt method, and statistical analyses were performed based on data distribution. CXCL10 was the most frequently detected transcript among the three study groups (ATB: 100%, CT: 89.5%, LTBI: 92.6%) and the most consistently detected circulating transcript across the independent household-contact cohort ( n = 50). Significant differences in the relative abundance of circulating transcripts were observed for CXCL10 ( p = 0.019), L6 ( p = 0.001), and CVIL ( p = 0.001) transcripts for the LTBI and ATB groups. CXCL10 , L6 , and CVIL showed higher relative transcript abundance in LTBI and lower relative abundance in ATB at the transcript level, suggesting their potential to distinguish infection states. LIMD2 and ARSA1 did not show consistent or statistically significant differences. This study provides preliminary evidence that circulating serum CXCL10 , L6 , and CVIL transcripts differ between participants classified as having LTBI and those with ATB. The circulating transcripts, including CXCL10 , L6 , and CVIL , showed significant differences between the ATB and LTBI groups, suggesting that these transcripts may have potential as candidate biomarkers for the early identification of LTBI. However, the findings require confirmation in larger, independently characterized, and longitudinally followed cohorts before their clinical diagnostic utility can be established.
No takes yet. Share an insight, caveat, or question.
Rathwita et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: